1. Home
  2. GXAI vs IMCC Comparison

GXAI vs IMCC Comparison

Compare GXAI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXAI
  • IMCC
  • Stock Information
  • Founded
  • GXAI 2021
  • IMCC 1980
  • Country
  • GXAI United States
  • IMCC Israel
  • Employees
  • GXAI N/A
  • IMCC N/A
  • Industry
  • GXAI
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • GXAI
  • IMCC Health Care
  • Exchange
  • GXAI Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • GXAI 7.5M
  • IMCC 7.5M
  • IPO Year
  • GXAI 2023
  • IMCC N/A
  • Fundamental
  • Price
  • GXAI $1.47
  • IMCC $2.20
  • Analyst Decision
  • GXAI
  • IMCC
  • Analyst Count
  • GXAI 0
  • IMCC 0
  • Target Price
  • GXAI N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • GXAI 502.4K
  • IMCC 16.1K
  • Earning Date
  • GXAI 03-26-2025
  • IMCC 03-27-2025
  • Dividend Yield
  • GXAI N/A
  • IMCC N/A
  • EPS Growth
  • GXAI N/A
  • IMCC N/A
  • EPS
  • GXAI N/A
  • IMCC N/A
  • Revenue
  • GXAI $2,979.00
  • IMCC $38,042,859.00
  • Revenue This Year
  • GXAI N/A
  • IMCC $22.59
  • Revenue Next Year
  • GXAI N/A
  • IMCC $32.86
  • P/E Ratio
  • GXAI N/A
  • IMCC N/A
  • Revenue Growth
  • GXAI N/A
  • IMCC N/A
  • 52 Week Low
  • GXAI $1.01
  • IMCC $1.61
  • 52 Week High
  • GXAI $19.20
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • GXAI 39.18
  • IMCC 46.55
  • Support Level
  • GXAI $1.35
  • IMCC $2.11
  • Resistance Level
  • GXAI $1.66
  • IMCC $2.42
  • Average True Range (ATR)
  • GXAI 0.14
  • IMCC 0.18
  • MACD
  • GXAI 0.00
  • IMCC 0.01
  • Stochastic Oscillator
  • GXAI 14.72
  • IMCC 27.27

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: